These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24004484)

  • 1. Measuring and estimating treatment effect on dichotomous outcome of a population.
    Wang X; Jin Y; Yin L
    Stat Methods Med Res; 2016 Oct; 25(5):1779-1790. PubMed ID: 24004484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point and interval estimation of baseline risk and treatment effect based on logistic model for observational studies.
    Wang X; Yin L
    Biom J; 2015 May; 57(3):441-52. PubMed ID: 25810034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal logistic models for non-compliance under randomized treatment with univariate binary response.
    Ten Have TR; Joffe M; Cary M
    Stat Med; 2003 Apr; 22(8):1255-83. PubMed ID: 12687654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.
    Zhang MM; Qian W; Qin YY; He J; Zhou YH
    World J Gastroenterol; 2015 Apr; 21(14):4345-57. PubMed ID: 25892886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational studies using propensity score analysis underestimated the effect sizes in critical care medicine.
    Zhang Z; Ni H; Xu X
    J Clin Epidemiol; 2014 Aug; 67(8):932-9. PubMed ID: 24774469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting of treatment effects from randomized trials: a plea for multivariable risk ratios.
    Groenwold RH; Moons KG; Peelen LM; Knol MJ; Hoes AW
    Contemp Clin Trials; 2011 May; 32(3):399-402. PubMed ID: 21195797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying noncollapsibility of the odds ratio with marginal structural and logistic regression models.
    Pang M; Kaufman JS; Platt RW
    Stat Methods Med Res; 2016 Oct; 25(5):1925-1937. PubMed ID: 24108272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covariate adjustment in randomized trials with binary outcomes: targeted maximum likelihood estimation.
    Moore KL; van der Laan MJ
    Stat Med; 2009 Jan; 28(1):39-64. PubMed ID: 18985634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
    Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
    Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Likelihood-based inference for bounds of causal parameters.
    Lee W; Sjölander A; Larsson A; Pawitan Y
    Stat Med; 2018 Dec; 37(30):4695-4706. PubMed ID: 30155912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary nonparametric analysis of covariance for logistic regression in a randomized clinical trial setting.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 Mar; 9(1):45-66. PubMed ID: 10091909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation in regression models for longitudinal binary data with outcome-dependent follow-up.
    Fitzmaurice GM; Lipsitz SR; Ibrahim JG; Gelber R; Lipshultz S
    Biostatistics; 2006 Jul; 7(3):469-85. PubMed ID: 16428260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quasi-likelihood estimation for relative risk regression models.
    Carter RE; Lipsitz SR; Tilley BC
    Biostatistics; 2005 Jan; 6(1):39-44. PubMed ID: 15618526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis.
    Du LJ; Chen BR; Kim JJ; Kim S; Shen JH; Dai N
    World J Gastroenterol; 2016 Mar; 22(12):3486-95. PubMed ID: 27022230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
    Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps.
    Nam SY; Park BJ; Ryu KH; Nam JH
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):449-54. PubMed ID: 26735158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication.
    Zou J; Dong J; Yu X
    Helicobacter; 2009 Oct; 14(5):97-107. PubMed ID: 19751434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children.
    Horvath A; Dziechciarz P; Szajewska H
    Aliment Pharmacol Ther; 2012 Sep; 36(6):534-41. PubMed ID: 22827718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.